From April 1, 2024 to June 30, 2024, the company has repurchased 0 shares, representing 0% for CNY 0 million. With this, the company has completed the repurchase of 2,020,000 shares, representing 1.02% for CNY 28.79 million under the buyback announced on August 31, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.61 CNY | -4.69% |
|
-7.92% | -37.31% |
Jul. 02 | Tranche Update on Zhejiang AngLiKang Pharmaceutical CO.,LTD.'s Equity Buyback Plan announced on August 31, 2023. | CI |
Jul. 02 | Anglikang Pharmaceutical's Two Drugs Get Marketing Nod | MT |
1st Jan change | Capi. | |
---|---|---|
-37.31% | 374M | |
+57.48% | 827B | |
-7.18% | 350B | |
+15.37% | 319B | |
+7.45% | 294B | |
+14.09% | 240B | |
+14.54% | 221B | |
-0.29% | 219B | |
+8.14% | 167B | |
-2.99% | 158B |
- Stock Market
- Equities
- 002940 Stock
- News Zhejiang AngLiKang Pharmaceutical CO.,LTD.
- Tranche Update on Zhejiang AngLiKang Pharmaceutical CO.,LTD.'s Equity Buyback Plan announced on August 31, 2023.